Neutron Therapeutics LLC is pioneering advancements in Boron Neutron Capture Therapy (BNCT), a specialized form of radiation therapy that aims to selectively target malignant cells while minimizing damage to surrounding healthy tissue. This innovative approach has the potential to streamline treatment protocols, allowing for the possibility of administering therapy in a single session rather than through multiple fractions. The company boasts a team of experienced scientists and engineers with over 20 years of expertise in the BNCT field, focusing on technical innovations and clinical research to enhance the effectiveness of this targeted treatment modality.

Central to Neutron Therapeutics' offerings is the nuBeam BNCT Suite, which features a compact, accelerator-based neutron source designed for use within hospital settings. This system utilizes a 2.6 MeV electrostatic proton accelerator paired with a rotating solid lithium target to generate neutrons, providing a reliable and cost-effective solution for high patient throughput. The nuBeam Suite encompasses all necessary components for BNCT treatment, including beam-shaping assemblies and patient positioning systems, ensuring a comprehensive and user-friendly therapeutic environment. Additionally, the company offers custom-designed shielding solutions to ensure safety during neutron radiation procedures.

United States

Neutron Therapeutics LLC is a pioneer in Boron Neutron Capture Therapy (BNCT) using our nuBeam platform, the world's only neutron beam for BNCT that conforms to IAEA international standard for clinical use.

Neutron Therapeutics LLC

Company Details